Theriva Biologics Inc. Dividends
The next dividend date for Theriva Biologics Inc. has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Theriva Biologics Inc. (TOVX)
More About Theriva Biologics Inc.
Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States. Its lead product candidate, VCN-01 (zabilugene almadenorepvec), a clinical stage oncolytic human adenovirus that is in Phase 1 clinical trials and Phase 2 VIRAGE trial for patients with pancreatic cancer, head and neck squamous cell carcinoma, ovarian cancer, colorectal cancer, and retinoblastoma. The company also develops VCN-11 for treating solid tumors; SYN-004 (ribaxamase), an oral capsule prophylactic therapy that is in Phase 1b/2a clinical trials for the prevention of acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant (HCT); and SYN-020, a recombinant oral formulation of the enzyme intestinal alkaline phosphatase (IAP) for multiple gastrointestinal and metabolic indications. In addition, it develops clinical stage products, such as SYN-006 to prevent aGVH, clostridioides difficile infection, and microbiome damage in patients treated with carbapenem antibiotics; and SYN-007 for preventing antibiotic associated diarrhea with oral ß-lactam antibiotics. The company has a license agreement with Rasayana Therapeutics, Inc. to research, develop, manufacture, and commercialize any product that includes SYN-020, as well as a clinical trial agreement with Washington University School of Medicine in St. Louis to conduct a Phase 1b/2a clinical trial of SYN-004. Theriva Biologics, Inc. is headquartered in Rockville, Maryland.
Owning Theriva Biologics Inc. Stock on the Dividend Date
If you own Theriva Biologics Inc. stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Theriva Biologics Inc. stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Theriva Biologics Inc. stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Theriva Biologics Inc. stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Theriva Biologics Inc. dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Theriva Biologics Inc. Dividends
You can contact us any time if you would like to ask questions about Theriva Biologics Inc. dividends or anything else related to the stock market.